Kataoka S, Aoki T, Watabe H
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Higashi-Nippon-Gakuen University, Hokkaido, Japan.
Hokkaido Igaku Zasshi. 1990 Jan;65(1):50-5.
A pregnancy-specific beta 1-glycoprotein (SP1) was purified from human placenta using either an ion-exchange column [method I] or an anti-SP1 antibody immunoadsorbent column [method II]. The yields were 5.2% with a total of 1.2 mg per placenta [method I], and 9. 4% with a total of 2.2 mg per placenta [method II], respectively. The physicochemical properties (molecular weight, sedimentation coefficient, amino acid composition etc.) of SP1 purified from human placenta by these methods are essentially the same as those of typical SP1. It is thus apparent from the present results that these SP1 from pregnant serum and human placenta cannot be distinguished immunologically and biochemically.
采用离子交换柱[方法I]或抗SP1抗体免疫吸附柱[方法II]从人胎盘中纯化出妊娠特异性β1-糖蛋白(SP1)。产量分别为5.2%,每个胎盘总量为1.2mg[方法I],以及9.4%,每个胎盘总量为2.2mg[方法II]。通过这些方法从人胎盘中纯化得到的SP1的物理化学性质(分子量、沉降系数、氨基酸组成等)与典型SP1的基本相同。因此,从目前的结果可以明显看出,来自孕妇血清和人胎盘的这些SP1在免疫学和生物化学上无法区分。